Please assess the completion status of the following clinical trial:

Trial Title: The AVATAR Trial: Applying VAcuum To Accomplish Reduced Wound Infections

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age 0-17 years old~* any emergency or elective laparoscopic procedure requiring an umbilical port~Exclusion Criteria:~* immunocompromise (acquired or iatrogenic)~* malignancy~* requiring blood transfusion within 6 weeks of surgery~* history of splenectomy~* significant comorbid conditions, such as severe cardiopulmonary disease~* presence of any chronic abdominal wound, cellulitis, or enterocutaneous fistula~* pregnancy~* smoker~* BMI \> 30~* inability to attend follow up~* language barrier

- Gender: ALL
- Minimum Age: None
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Vacuum (Type: EXPERIMENTAL): the group of patients assigned to application of vacuum to the wound dressing
- Control (Type: ACTIVE_COMPARATOR): The dressing for the umbilical port site will be the same as the experimental group, except for the application of vacuum. The control group will have no vacuum applied to the wound dressing.

Based on this trial design, predict the completion outcome and termination type (if applicable).